SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-326023
Filing Date
2019-12-30
Accepted
2019-12-30 16:31:12
Documents
13
Period of Report
2019-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d851034d8k.htm   iXBRL 8-K 44761
2 EX-4.1 d851034dex41.htm EX-4.1 881231
  Complete submission text file 0001193125-19-326023.txt   1238719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20191230.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20191230_lab.xml EX-101.LAB 18093
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20191230_pre.xml EX-101.PRE 11402
15 EXTRACTED XBRL INSTANCE DOCUMENT d851034d8k_htm.xml XML 3451
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 191316946
SIC: 2834 Pharmaceutical Preparations